Alexandra Taraboletti
A bulk of already established screens measure metabolites from easily accessible samples like blood, urine, or saliva to answer questions about standard health or injury. However, many new panels are actively being discovered to answer new questions, using metabolites as markers. The work to uncover new metabolite markers of human health and disease is part of a growing field called metabolomics.
My research is part of an effort to identify metabolite markers in blood that are associated with radiation exposure. Understanding radiation exposure is important for patients receiving therapeutic radiation (for cancer treatment), those exposed during a radiation accident or event, and for future astronauts as they travel deeper into space and away from our protective atmosphere. We need a fast and reliable measure of radiation dose in the likely event that a patient is unaware of how much radiation they received. With a quick analysis, using metabolites, we hope to monitor and appropriately treat patients (even the ones in space) based on their metabolite levels. This is just one of many problems we can solve using the information from metabolomics – and I find it radiant!